Synthetic Antibody Prevents COVID Virus Replication

Although a few types of COVID-19 vaccines have begun to be distributed around the world, a unique technology, developed at University of California, San Francisco, may offer an even more direct way to prevent the coronavirus from multiplying within the body. The UCSF team created a synthetic antibody that prevents SARS-CoV-2, the virus that causes COVID-19, from binding to human cells.


Deploy this technology today



Next Article

  • 3 Big Predictions for Digital Health in 2021

    3 Big Predictions for Digital Health in 2021

    The coronavirus pandemic set in motion a cascade of changes in healthcare, and no sector was impacted more than digital health. The fledgling industry rapidly accelerated as COVID-19 changed …

    Posted Feb 3, 2021 Digital Health

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Mar 28, 2024 at 3:00am